Related references
Note: Only part of the references are listed.Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-κB pathways in subtypes of diffuse large B-cell lymphoma
Lloyd T. Lam et al.
BLOOD (2008)
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma
Georg Lenz et al.
SCIENCE (2008)
After a decade of study-ING, a PHD for a versatile family of proteins
Mohamed A. Soliman et al.
TRENDS IN BIOCHEMICAL SCIENCES (2007)
Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma
Georg Lenz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
High-throughput oncogene mutation profiling in human cancer
Roman K. Thomas et al.
NATURE GENETICS (2007)
Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation
E. Haralambieva et al.
LEUKEMIA (2006)
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling
Michael Hummel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas
WY Chen et al.
BLOOD (2006)
Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction
S Bea et al.
BLOOD (2005)
Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma
H Tagawa et al.
BLOOD (2005)
FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations
I Wlodarska et al.
LEUKEMIA (2005)
High-resolution genomic profiles of human lung cancer
G Tonon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Positive and negative regulation of nuclear factor-κB-mediated transcription by IκB-ξ, an inducible nuclear protein
M Motoyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
High-resolution characterization of the pancreatic adenocarcinoma genome
AJ Aguirre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma
A Ota et al.
CANCER RESEARCH (2004)
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma
A Rosenwald et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma
G Wright et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma
KJ Savage et al.
BLOOD (2003)
Lymphoid malignancies: The dark side of B-cell differentiation
AL Shaffer et al.
NATURE REVIEWS IMMUNOLOGY (2002)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells
RE Davis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Share Paper
